O. Vaccaro et al., Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) and severe obesity: a case-control study, INT J OBES, 24(9), 2000, pp. 1195-1199
OBJECTIVE: To explore the association of the Pro12Ala mutation in the perox
isome proliferator-activated receptor gamma 2 with severe obesity and the f
eatures of the metabolic syndrome in a population-based sample of Caucasian
s.
PARTICIPANTS AND METHODS: The study is based on a case-control design: 95 n
on-diabetic severely obese (body mass index, BMI > 35 kg/m(2)) cases and 28
0 normal weight (BMI < 25 kg/m(2)), age- and sex-matched controls selected
from the same population were studied. Height, weight, waist circumference,
as well as blood pressure were measured according to a standard protocol.
BMI at age 25 y was calculated on the basis of current height and reported
weight at age 25 y Biochemical measurements included fasting glucose, trigl
ycerides. high-density lipoprotein cholesterol and insulin. DNA analysis wa
s conducted by PCR and gel electrophoresis.
RESULTS: Age and gender distribution were similar in obese and normal weigh
t participants. The percentage of people with the Pro12Ala mutation was not
significantly different in obese or normal weight participants (20% and ;1
5%, respectively; P = 0.32), Conversely, in obese participants with obesity
starling in early adulthood lie with BMI at age 25 above 26.9 kg/m(2) whic
h represents the median of the whole obese group), the Pro12Ala mutation wa
s observed significantly more frequently than in the normal weight controls
(29% vs 15%; chi square = 4.5, P < 0.05; odds ratio 2.4; 95% CI 1.03-5.36)
. No association of the Pro12Ala variant with any of the component of the m
etabolic syndrome measured in the study was observed in either obese, juven
ile obese or normal weight participants.
CONCLUSIONS: Results of this study indicate that the Pro12Ala mutation does
not play a major role as a determinant of severe obesity and/or features o
f the metabolic syndrome in the general population. However, this mutation
may be of greater importance as a contributor to early onset obesity.